MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mäkelä, R.
Right arrow Articles by Korpi, E. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mäkelä, R.
Right arrow Articles by Korpi, E. R.

0026-895X/97/030380-09$3.00/0
Copyright © by The American Society for Pharmacology and Experimental Therapeutics
All rights of reproduction in any form reserved.
MOLECULAR PHARMACOLOGY 52:380-388 (1997).

Cerebellar gamma -Aminobutyric Acid Type A Receptors: Pharmacological Subtypes Revealed by Mutant Mouse Lines

Riikka Mäkelä, Mikko Uusi-Oukari, Gregg E. Homanics, Joseph J. Quinlan, Leonard L. Firestone, William Wisden, and Esa R. Korpi

Department of Mental Health and Alcohol Research, National Public Health Institute, Helsinki, Finland (R.M., E.R.K.), Tampere Brain Research Center, University of Tampere Medical School, Tampere, Finland (R.M.), Department of Anesthesiology/Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261 (G.E.H., J.L.Q., L.L.F.), Medical Research Council Laboratory of Molecular Biology, Medical Research Council Centre, Cambridge CB2 2QH, UK (W.W.), and Department of Pharmacology and Clinical Pharmacology, University of Turku, Turku, Finland (M.U.-O., E.R.K.)

The vast molecular heterogeneity of brain gamma -aminobutyric acid type A (GABAA) receptors forms the basis for receptor subtyping. Using autoradiographic techniques, we established the characteristics of cerebellar granule cell GABAA receptors by comparing wild-type mice with those with a targeted disruption of the alpha 6 subunit gene. Cerebellar granule cells of alpha 6-/- animals have severe deficits in high affinity [3H]muscimol and [3H]SR 95531 binding to GABA sites, in agonist-insensitive [3H]Ro 15-4513 binding to benzodiazepine sites, and in furosemide-induced increases in tert-[35S]butylbicyclophosphorothionate binding to picrotoxin-sensitive convulsant sites. These observations agree with the known specific properties of these sites on recombinant alpha 6beta 2/3gamma 2 receptors. In the presence of GABA concentrations that fail to activate alpha 1 subunit-containing receptors, methyl-6,7-dimethoxy-4-ethyl-beta -carboline (30 µM), allopregnanolone (100 nM), and Zn2+ (10 µM) are less efficacious in altering tert-[35S]butylbicyclophosphorothionate binding in the granule cell layer of the alpha 6-/- than alpha 6+/+ animals. These data concur with the deficiency of the cerebellar alpha 6 and delta  subunit-containing receptors in the alpha 6-/- animals and could also account for the decreased affinity of [3H]muscimol binding to alpha 6-/- cerebellar membranes. Predicted additional alterations in the cerebellar receptors of the mutant mice may explain a surplus of methyl-6,7-dimethoxy-4-ethyl-beta -carboline-insensitive receptors in the alpha 6-/- granule cell layer and an increased diazepam-sensitivity in the molecular layer. These changes may be adaptive consequences of altered GABAA receptor subunit expression patterns in response to the loss of two subunits (alpha  and delta ) from granule cells.


Copyright © by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
A.-M. Linden, M. I. Aller, E. Leppa, P. H. Rosenberg, W. Wisden, and E. R. Korpi
K+ Channel TASK-1 Knockout Mice Show Enhanced Sensitivities to Ataxic and Hypnotic Effects of GABAA Receptor Ligands
J. Pharmacol. Exp. Ther., October 1, 2008; 327(1): 277 - 286.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. M. Sonner, M. Cascio, Y. Xing, M. S. Fanselow, J. E. Kralic, A. L. Morrow, E. R. Korpi, S. Hardy, B. Sloat, E. I. Eger II, et al.
{alpha}1 Subunit-Containing GABA Type A Receptors in Forebrain Contribute to the Effect of Inhaled Anesthetics on Conditioned Fear
Mol. Pharmacol., July 1, 2005; 68(1): 61 - 68.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
J. L Fisher
The {alpha}1 and {alpha}6 subunit subtypes of the mammalian GABAA receptor confer distinct channel gating kinetics
J. Physiol., December 1, 2004; 561(2): 433 - 448.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. E. Kralic, E. R. Korpi, T. K. O'Buckley, G. E. Homanics, and A. L. Morrow
Molecular and Pharmacological Characterization of GABAA Receptor alpha 1 Subunit Knockout Mice
J. Pharmacol. Exp. Ther., September 1, 2002; 302(3): 1037 - 1045.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. M. Mihalek, P. K. Banerjee, E. R. Korpi, J. J. Quinlan, L. L. Firestone, Z.-P. Mi, C. Lagenaur, V. Tretter, W. Sieghart, S. G. Anagnostaras, et al.
Attenuated sensitivity to neuroactive steroids in gamma -aminobutyrate type A receptor delta subunit knockout mice
PNAS, October 26, 1999; 96(22): 12905 - 12910.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T.-J. Zhao, M. Li, T. H. Chiu, and H. C. Rosenberg
Decreased Benzodiazepine Binding with Little Effect on gamma -Aminobutyric Acid Binding in Rat Brain After Treatment with Antisense Oligodeoxynucleotide to the gamma -Aminobutyric AcidA Receptor Gamma-2 Subunit
J. Pharmacol. Exp. Ther., November 1, 1998; 287(2): 752 - 759.
[Abstract] [Full Text]


Home page
Pharmacol. Rev.Home page
E. A. Barnard, P. Skolnick, R. W. Olsen, H. Mohler, W. Sieghart, G. Biggio, C. Braestrup, A. N. Bateson, and S. Z. Langer
International Union of Pharmacology. XV. Subtypes of gamma -Aminobutyric AcidA Receptors: Classification on the Basis of Subunit Structure and Receptor Function
Pharmacol. Rev., June 1, 1998; 50(2): 291 - 314.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics